Related Experiment Video
Updated: Jan 11, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson's disease: a 12-year longitudinal
Kyoungwon Baik1,2, Minwoong Kang3, Yu Jeong Park4
1Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Background:
Various comorbidities contribute to mortality in patients with Parkinson's disease (PD). Although growing evidence demonstrates that chronic kidney disease (CKD) increases the risk of developing PD, the effect of CKD on all-cause mortality remains unclear.
Methods:
We enrolled 59,293 patients aged ≥40 years with de novo PD between 2009 and 2015, using de-identified data from the Korean National Health Insurance Service. Cox proportional hazards regression analysis using the presence of CKD or proteinuria as a predictor was performed to investigate the association between CKD, proteinuria, and mortality. For sensitivity analysis, the degree of eGFR or proteinuria were used as predictors in place of CKD/proteinuria.
Results:
Parkinson's disease patients with CKD (hazard ratio [HR] = 1.240, 95% confidence interval [CI] 1.190-1.283) and proteinuria (HR = 1.543, 95% CI 1.457-1.634) had a higher risk of mortality, even after controlling for confounding factors. The degree of kidney dysfunction (p < 0.001) and proteinuria (p < 0.001) were associated with an increased HR for mortality. Furthermore, female patients with CKD were more vulnerable to mortality than male patients (p for sex × CKD < 0.001); however, there was no sex-specific vulnerability of proteinuria to mortality (p for sex × proteinuria = 0.603).
Conclusion:
Chronic kidney disease and proteinuria were associated with a higher all-cause mortality in patients with PD in a dose-dependent manner. Furthermore, these results highlight that strategies for controlling kidney function are necessary to reduce mortality in patients with PD.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Parkinson's Disease: Overview

